STOCK TITAN

Ambev SEC Filings

ABEV NYSE

Welcome to our dedicated page for Ambev SEC filings (Ticker: ABEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Ambev S.A. (ABEV) SEC filings page brings together the company’s disclosures as a foreign private issuer with securities listed on the New York Stock Exchange. Ambev files an annual report on Form 20-F, as highlighted in multiple press releases announcing the availability of its annual reports for successive years. These 20-F filings contain the company’s complete audited financial statements, and the press releases note that American Depositary Receipt holders may request hard copies free of charge.

In addition to its annual reports, Ambev regularly furnishes Form 6-K current reports. The examples provided include notices to shareholders about ordinary shareholders’ meetings, extracts of minutes from Board of Directors meetings, and detailed explanations of decisions to distribute dividends and interest on capital based on extraordinary balance sheets. Other 6-Ks disclose policies on executive remuneration and the grant of stock options and restricted shares, as well as a policy on hiring services related or not related to auditing, which sets conditions for engaging independent auditors and lists non-authorized services to preserve auditor independence.

Ambev also uses Form 6-K to report related party transactions, such as its agreement with its controlling shareholder Anheuser-Busch InBev SA/NV for the use of the BEES B2B digital platform, and to provide consolidated and individual forms under Article 11 of CVM Instruction 358/2002 that detail management and related persons’ transactions in Ambev shares and ADRs. These forms show initial and final positions, deliveries of restricted shares, purchases, and sales.

On Stock Titan, these filings can be paired with AI-powered summaries that explain the key points of lengthy documents, highlight items such as dividend approvals, interest on capital distributions, insider share movements, and policy changes, and help readers navigate Ambev’s 20-F and 6-K disclosures more efficiently.

Rhea-AI Summary

Ambev S.A. approved an extraordinary balance sheet as of November 30, 2025 to support new shareholder payouts. The board declared dividends of R$0.4612 per share, with R$0.3459 per share counted toward the mandatory minimum dividend for fiscal year 2025 and R$0.1153 per share as additional dividends from the profit reserve. These dividends are scheduled to be paid on December 30, 2025 without income tax withholding.

The board also approved interest on capital of R$0.2690 per share, based on the profit reserve, which will not be used to meet the mandatory minimum dividend and will result in a net payment of R$0.2286 per share by December 31, 2026. Additionally, board member Nelson José Jamel resigned from the board and People Committee effective January 1, 2026, and Ricardo Manuel Frangatos Pires Moreira was elected to the People Committee from that date, while the board seat will remain vacant until the 2026 annual meeting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Ambev S.A. announced that its board of directors approved a new shareholder distribution, including cash dividends and interest on own capital. The distributions will be based on the shareholding position on December 18, 2025 for shares traded on B3 in Brazil and December 22, 2025 for ADRs traded on the New York Stock Exchange. Shares and ADRs will trade ex-dividends and ex-interest on own capital starting on December 19, 2025, meaning investors buying from that date will not be entitled to these payments.

The interest on own capital is scheduled to be paid by December 31, 2026, with the exact payment date to be set at a future board meeting and disclosed to the market. Ambev highlights its focus on creating value for shareholders and on maintaining transparency in how it communicates material information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Ambev S.A. reported its own transactions in Ambev securities for November 2025, focusing on movements in treasury shares. The company started the month holding 169,171,789 common shares in treasury and no ADRs. During the month, it delivered 106,294 common shares as restricted shares at a reference price of R$12.91 per share, totaling R$1,372,255.54, and purchased 17,210 common shares directly from the company at R$13.77 per share, totaling R$236,981.70. After these transactions, Ambev ended November with 169,082,705 common shares in treasury and no ADRs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Ambev S.A. furnished a Form 6-K reporting the share and ADR positions of its board, executive management, and fiscal council for the period from November 1 to 30, 2025, as required by Brazilian CVM Instruction 358. The consolidated forms show the board of directors holding 12,107,569 common shares and 468,040 ADRs, executive management holding 3,783,056 common shares and 19,790 ADRs, and the fiscal council holding 2,500 common shares. Initial and final balances for each group are the same over the period, indicating no change in these reported positions. Each ADR represents one common share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Ambev S.A. (ABEV) reported October 2025 insider‑trading compliance information under Article 11 of CVM Instruction 358/2002. The company executed a single movement: delivery of 33,615 common shares from treasury as restricted shares on October 2, at a stated price of R$11.99 per share, for a reported volume of R$403,043.85.

Ambev’s treasury share balance was 169,205,404 common shares at the start of October and 169,171,789 at month‑end. The ADR common balance was 0 throughout the period.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Ambev S.A. (ABEV) filed a Form 6-K detailing insider securities positions for October 1–31, 2025. The report consolidates holdings of the Board of Directors, Management, and Fiscal Council under Article 11 of CVM Instruction 358/2002. Initial and final balances were unchanged over the period.

The Board of Directors held 12,107,569 common shares and 468,040 ADRs. Management held 3,783,056 common shares and 19,790 ADRs. The Fiscal Council held 2,500 common shares. Each ADR equals 1 share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Ambev (ABEV) furnished an amended 6-K with its 3Q25 earnings call presentation, highlighting profit and commercial momentum. EPS grew 8% in 3Q25, supported by EBITDA growth with margin expansion. Net revenue increased, with NR/hl up 7%, and the company reported strong brand health across key markets.

Premium and Super Premium volumes rose more than 9%. The company also announced a share buyback program of R$2.5 billion. Its digital ecosystem advanced: Zé Delivery GMV +7% with +9% AOV, and BEES Marketplace reached BRL 8.0 billion annualized GMV. Cost discipline remained a focus as cash COGS/hl trailed NR/hl.

Year-to-date 2025, EPS increased 7% with continued EBITDA growth and margin expansion. Segment EBITDA contributions were led by Brazil Beer 48%, followed by CAC 18%, LAS 14%, Canada 12%, and Brazil NAB 8%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Ambev S.A. approved a share buyback program to repurchase up to 208,000,000 common shares, mainly for cancellation, effective until April 29, 2027.

The company reported 4,253,039,958 outstanding shares and 169,205,404 shares in treasury at approval. Purchases will be recorded as a debit to the capital reserve on the balance sheet dated as of September 30, 2025. If the full amount is repurchased, the total payment would be approximately R$ 2,500,000,000.00, based on the closing share price on October 29, 2024, which the board noted equals about 15% of the company’s cash, and stated this would not affect obligations to creditors or mandatory dividends.

Transactions will be executed on the Brazilian stock exchange via Santander Corretora, Ágora Corretora, and Goldman Sachs do Brasil.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Ambev S.A. (ABEV) furnished a Form 6-K detailing an updated Manual on Disclosure and Securities Trading Policy. The Manual aligns with CVM Ruling No. 44/21 and consolidates rules for handling material information, public disclosure, and trading by insiders and related parties.

Key provisions include centralized oversight by the Investor Relations Officer, who is responsible for communicating and disclosing any Material Act or Fact through designated channels, including Valor Econômico’s portal, the company’s IR website, and CVM systems. The policy prohibits trading before disclosure of material information and imposes a 15-day blackout before publishing quarterly (ITR) and annual (DFP) financial information. It also outlines exceptions, such as transactions under approved stock plans and properly structured Individual Investment Plans with predefined rules and a minimum three-month effectiveness period.

The Manual mandates Adhesion Forms for Bound Persons and prescribes notification and reporting procedures, including ownership change disclosures when crossing 5%, 10%, 15% thresholds and successive levels. Amendments were approved by the Board on October 29, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Ambev (ABEV)?

The current stock price of Ambev (ABEV) is $2.8 as of January 13, 2024.

What is the market cap of Ambev (ABEV)?

The market cap of Ambev (ABEV) is approximately 44.0B.

ABEV Rankings

ABEV Stock Data

44.04B
15.62B
Beverages - Brewers
Consumer Defensive
Link
Brazil
São Paulo

ABEV RSS Feed